Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1Condition 2Condition 3
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood insulin amountRS:0000916WKY/NHsdfemale119 days10CMO:0000342plasma insulin level20mU/l2.57.9057MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 11614fasting (for 16 hours)glucose solution (2 g/kg)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood insulin amountRS:0000916WKY/NHsdmale119 days10CMO:0000342plasma insulin level64.1mU/l9.730.6741MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 11612fasting (for 16 hours)glucose solution (2 g/kg)
252Baum AE, et al., Endocrinology 2004 Oct 28;.blood thyroid-stimulating hormone amountRS:0000916WKY/NHsdfemale0 days to 70 days15CMO:0001248serum thyroid stimulating hormone levelserum tsh3ng/ml0.05420.21MMO:0000073radioimmunoassay0.0naive control condition67898naive control condition
252Baum AE, et al., Endocrinology 2004 Oct 28;.blood thyroid-stimulating hormone amountRS:0000916WKY/NHsdmale0 days to 70 days16CMO:0001248serum thyroid stimulating hormone levelserum tsh5.28ng/ml0.291.16MMO:0000073radioimmunoassay0.0naive control condition67897naive control condition
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood creatinine amountRS:0000916WKY/NHsdmale0 days8CMO:0000537plasma creatinine level0.31787282mg/dl0.01130.032MMO:0000306plasma creatinine analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99174controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood creatinine amountRS:0000916WKY/NHsdmale0 days7CMO:0000537plasma creatinine level0.30090452mg/dl0.00790.021MMO:0000306plasma creatinine analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99173controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood creatinine amountRS:0000916WKY/NHsdmale0 days8CMO:0000537plasma creatinine level0.35180942mg/dl0.0170.048MMO:0000306plasma creatinine analysis0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99172standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood creatinine amountRS:0000916WKY/NHsdmale0 days7CMO:0000537plasma creatinine level0.30882306mg/dl0.01020.0269MMO:0000306plasma creatinine analysis0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99171standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
141Lan H, et al., Genetics 2001 Jan;157(1):331-9mammary gland integrity traitRS:0000916WKY/NHsdfemale174 days to 169 days17CMO:0000343mammary tumor number3X3 mm diameter or larger0MMO:0000344necropsy7,12-dimethyltetraphene (DMBA) (65 mg/kg) 117417,12-dimethyltetraphene (DMBA) (65 mg/kg)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.arterial blood pressure traitRS:0000916WKY/NHsdmale0 days8CMO:0000009mean arterial blood pressure124mmHg4.011.3137MMO:0000577intra-aortic radiotelemetry0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99190controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.arterial blood pressure traitRS:0000916WKY/NHsdmale0 days7CMO:0000009mean arterial blood pressure116mmHg1.02.6458MMO:0000577intra-aortic radiotelemetry0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99189controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.arterial blood pressure traitRS:0000916WKY/NHsdmale0 days8CMO:0000009mean arterial blood pressure128mmHg3.08.4853MMO:0000577intra-aortic radiotelemetry0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99188standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.arterial blood pressure traitRS:0000916WKY/NHsdmale0 days7CMO:0000009mean arterial blood pressure101mmHg0.92.3812MMO:0000577intra-aortic radiotelemetry0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99187standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0000059plasma chloride level104.8mmol/l1.84.7624MMO:0000037automated blood electrolyte analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99169controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0000059plasma chloride level109.1mmol/l1.02.8284MMO:0000037automated blood electrolyte analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99170controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0000059plasma chloride level100.5mmol/l0.51.4142MMO:0000037automated blood electrolyte analysis0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99168standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0000059plasma chloride level98.2mmol/l1.12.9103MMO:0000037automated blood electrolyte analysis0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99167standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
105Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8adrenal gland massRS:0000916WKY/NHsdfemale112 days20CMO:0000164both adrenal glands wet weight65.8mg1.88.0498MMO:0000005post excision weight measurementnaive control condition11602naive control condition
105Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8adrenal gland massRS:0000916WKY/NHsdmale112 days24CMO:0000164both adrenal glands wet weight43mg1.25.8788MMO:0000005post excision weight measurementnaive control condition11600naive control condition
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood glucose amountRS:0000916WKY/NHsdfemale119 days10CMO:0000042plasma glucose level84.3mg/dl6.921.8197MMO:0000315plasma glucose analysis0fasting (for 16 hours) then glucose solution (2 g/kg) 13184fasting (for 16 hours)glucose solution (2 g/kg)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood glucose amountRS:0000916WKY/NHsdfemale119 days10CMO:0000042plasma glucose level163.7mg/dl7.222.7684MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 13183fasting (for 16 hours)glucose solution (2 g/kg)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood glucose amountRS:0000916WKY/NHsdfemale105 days10CMO:0000042plasma glucose level151.6mg/dl4.714.8627MMO:0000315plasma glucose analysis0physical restraint in tube type rodent restrainer (for 0.5 hours)13182physical restraint in tube type rodent restrainer (for 0.5 hours)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood glucose amountRS:0000916WKY/NHsdmale105 days10CMO:0000042plasma glucose level153.5mg/dl6.319.9223MMO:0000315plasma glucose analysis0physical restraint in tube type rodent restrainer (for 0.5 hours)13175physical restraint in tube type rodent restrainer (for 0.5 hours)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood glucose amountRS:0000916WKY/NHsdmale119 days10CMO:0000042plasma glucose level98.1mg/dl2.57.9057MMO:0000315plasma glucose analysis0fasting (for 16 hours) then glucose solution (2 g/kg) 13174fasting (for 16 hours)glucose solution (2 g/kg)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood glucose amountRS:0000916WKY/NHsdmale119 days10CMO:0000042plasma glucose level173.8mg/dl5.517.3925MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 13173fasting (for 16 hours)glucose solution (2 g/kg)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood sodium amountRS:0000916WKY/NHsdmale0 days8CMO:0000060plasma sodium level139.4mmol/l1.74.8083MMO:0000037automated blood electrolyte analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99162controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood sodium amountRS:0000916WKY/NHsdmale0 days7CMO:0000060plasma sodium level141.4mmol/l2.15.5561MMO:0000037automated blood electrolyte analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99161controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood sodium amountRS:0000916WKY/NHsdmale0 days8CMO:0000060plasma sodium level137.8mmol/l2.36.5054MMO:0000037automated blood electrolyte analysis0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99160standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood sodium amountRS:0000916WKY/NHsdmale0 days7CMO:0000060plasma sodium level143.7mmol/l4.411.6413MMO:0000037automated blood electrolyte analysis0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99159standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.glomerular filtration traitRS:0000916WKY/NHsdmale0 days8CMO:0000765creatinine clearance3.5ml/min0.20.5657MMO:0000275urine creatinine analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99182controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.glomerular filtration traitRS:0000916WKY/NHsdmale0 days7CMO:0000765creatinine clearance3.5ml/min0.30.7937MMO:0000275urine creatinine analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99181controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.glomerular filtration traitRS:0000916WKY/NHsdmale0 days8CMO:0000765creatinine clearance3.1ml/min0.51.4142MMO:0000275urine creatinine analysis0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99180standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.glomerular filtration traitRS:0000916WKY/NHsdmale0 days7CMO:0000765creatinine clearance3.1ml/min0.51.3229MMO:0000275urine creatinine analysis0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99179standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood potassium amountRS:0000916WKY/NHsdmale0 days8CMO:0000061plasma potassium level4.4mmol/l0.41.1314MMO:0000037automated blood electrolyte analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99166controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood potassium amountRS:0000916WKY/NHsdmale0 days7CMO:0000061plasma potassium level4.2mmol/l0.30.7937MMO:0000037automated blood electrolyte analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99165controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood potassium amountRS:0000916WKY/NHsdmale0 days8CMO:0000061plasma potassium level4.2mmol/l0.30.8485MMO:0000037automated blood electrolyte analysis0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99164standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood potassium amountRS:0000916WKY/NHsdmale0 days7CMO:0000061plasma potassium level3.9mmol/l0.20.5292MMO:0000037automated blood electrolyte analysis0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99163standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22body massRS:0000916WKY/NHsdfemale119 days10CMO:0000012body weight230g3.210.1193MMO:0000016body weighing method0fasting (for 16 hours)11610fasting (for 16 hours)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22body massRS:0000916WKY/NHsdmale119 days10CMO:0000012body weight352g4.514.2302MMO:0000016body weighing method0fasting (for 16 hours)11608fasting (for 16 hours)
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.locomotor behavior traitRS:0000916WKY/NHsdfemale88 days to 77 days22CMO:0000960number of entries into a discrete space in an experimental apparatusin 10min; unprompted6.21.42846.7MMO:0000258open field apparatus method600.0naive control condition75706naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.locomotor behavior traitRS:0000916WKY/NHsdmale88 days to 77 days28CMO:0000960number of entries into a discrete space in an experimental apparatusin 10min; unprompted40.86934.6MMO:0000258open field apparatus method600.0naive control condition75704naive control condition
105Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8blood corticosterone amountRS:0000916WKY/NHsdfemale105 days20CMO:0001173plasma corticosterone level584.5ng/ml33.5149.8166MMO:0000073radioimmunoassay0physical restraint (for 0.2 hours)13128physical restraint (for 0.2 hours)
105Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8blood corticosterone amountRS:0000916WKY/NHsdmale105 days24CMO:0001173plasma corticosterone levelng/ml287.5ng/ml21.0102.8786MMO:0000073radioimmunoassay0physical restraint (for 0.2 hours)13124physical restraint (for 0.2 hours)
105Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8blood corticosterone amountRS:0000916WKY/NHsdfemale105 days20CMO:0001173plasma corticosterone level113ng/ml18.984.5234MMO:0000073radioimmunoassaynaive control condition13121naive control condition
105Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8blood corticosterone amountRS:0000916WKY/NHsdmale105 days24CMO:0001173plasma corticosterone levelng/ml31.7ng/ml4.220.5757MMO:0000073radioimmunoassaynaive control condition13118naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.grooming behavior traitRS:0000916WKY/NHsdmale88 days to 77 days26CMO:0001749duration of grooming in an experimental apparatusin 10min82.4s12.335762.9MMO:0000559defensive burying test600.0defensive burying apparatusnaive control condition75702naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.grooming behavior traitRS:0000916WKY/NHsdfemale88 days to 77 days16CMO:0001749duration of grooming in an experimental apparatusin 10min97.9s17.7571.0MMO:0000559defensive burying test600.0defensive burying apparatusnaive control condition75700naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.grooming behavior traitRS:0000916WKY/NHsdfemale88 days to 77 days22CMO:0001749duration of grooming in an experimental apparatusin 10min42.5s6.118928.7MMO:0000258open field apparatus method600.0naive control condition75696naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.grooming behavior traitRS:0000916WKY/NHsdmale88 days to 77 days28CMO:0001749duration of grooming in an experimental apparatusin 10min35.3s7.483739.6MMO:0000258open field apparatus method600.0naive control condition68654naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.body movement coordination traitRS:0000916WKY/NHsdfemale88 days to 77 days22CMO:0001752number of rearing movements in an experimental apparatusin 10min20.52.259910.6MMO:0000258open field apparatus method600.0naive control condition75692naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.body movement coordination traitRS:0000916WKY/NHsdmale88 days to 77 days28CMO:0001752number of rearing movements in an experimental apparatusin 10min9.61.37967.3MMO:0000258open field apparatus method600.0naive control condition75698naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.body movement coordination traitRS:0000916WKY/NHsdmale88 days to 77 days26CMO:0001752number of rearing movements in an experimental apparatusin 10min17.81.45137.4MMO:0000559defensive burying test600.0defensive burying apparatusnaive control condition75694naive control condition
972Baum AE, et al., Behav Brain Res. 2006 Feb 17;.body movement coordination traitRS:0000916WKY/NHsdfemale88 days to 77 days16CMO:0001752number of rearing movements in an experimental apparatusin 10min33.82.6510.6MMO:0000559defensive burying test600.0defensive burying apparatusnaive control condition68652naive control condition
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin potassium amountRS:0000916WKY/NHsdmale0 days8CMO:0002773skin potassium level to skin water level ratioskin k/h2o69mmol/l2.57.0711MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99158controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin potassium amountRS:0000916WKY/NHsdmale0 days7CMO:0002773skin potassium level to skin water level ratioskin k/h2o71mmol/l3.07.9373MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99157controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin potassium amountRS:0000916WKY/NHsdmale0 days8CMO:0002773skin potassium level to skin water level ratioskin k/h2o75mmol/l1.85.0912MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99156standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin potassium amountRS:0000916WKY/NHsdmale0 days7CMO:0002773skin potassium level to skin water level ratioskin k/h2o80mmol/l1.12.9103MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99155standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin mineral amountRS:0000916WKY/NHsdmale0 days8CMO:0002772skin potassium level plus skin sodium level to skin water level ratioskin na+k/h2o0.1710.0040.0113MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99146controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin mineral amountRS:0000916WKY/NHsdmale0 days7CMO:0002772skin potassium level plus skin sodium level to skin water level ratioskin na+k/h2o0.1760.0080.0212MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99145controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin mineral amountRS:0000916WKY/NHsdmale0 days8CMO:0002772skin potassium level plus skin sodium level to skin water level ratioskin na+k/h2o0.1670.0030.0085MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99144standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin mineral amountRS:0000916WKY/NHsdmale0 days7CMO:0002772skin potassium level plus skin sodium level to skin water level ratioskin na+k/h2o0.170.0010.0026MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99143standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood cystatin C amountRS:0000916WKY/NHsdmale0 days8CMO:0002778plasma cystatin C level3.9mg/l0.30.8485MMO:0000352automated plasma protein analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99178controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood cystatin C amountRS:0000916WKY/NHsdmale0 days7CMO:0002778plasma cystatin C level3.5mg/l0.20.5292MMO:0000352automated plasma protein analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99177controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood cystatin C amountRS:0000916WKY/NHsdmale0 days8CMO:0002778plasma cystatin C levelplasma cystatin c4.7mg/l0.30.8485MMO:0000352automated plasma protein analysis0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99176standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.blood cystatin C amountRS:0000916WKY/NHsdmale0 days7CMO:0002778plasma cystatin C level4mg/l0.61.5875MMO:0000352automated plasma protein analysis0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99175standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.urine sodium amountRS:0000916WKY/NHsdmale0 days8CMO:0000760urine sodium excretion rate34.3mEq/d1.85.0912MMO:0000434urine sodium analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99186controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.urine sodium amountRS:0000916WKY/NHsdmale0 days7CMO:0000760urine sodium excretion rate41.9mEq/d5.213.7579MMO:0000434urine sodium analysis0.0controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99185controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.urine sodium amountRS:0000916WKY/NHsdmale0 days8CMO:0000760urine sodium excretion rate1.1mEq/d0.10.2828MMO:0000434urine sodium analysis0.0standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99184standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.urine sodium amountRS:0000916WKY/NHsdmale0 days7CMO:0000760urine sodium excretion ratemmol/d1mEq/d0.20.5292MMO:0000434urine sodium analysis0.0standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99183standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin water amountRS:0000916WKY/NHsdmale0 days8CMO:0002771skin water level to skin dry weight ratioskin h2o ml/g1.522ml/g0.0040.0113MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99142controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin water amountRS:0000916WKY/NHsdmale0 days7CMO:0002771skin water level to skin dry weight ratioskin h2o ml/g1.432ml/g0.0320.0847MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99141controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin water amountRS:0000916WKY/NHsdmale0 days8CMO:0002771skin water level to skin dry weight ratioskin h2o ml/g1.208ml/g0.0190.0537MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99140standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin water amountRS:0000916WKY/NHsdmale0 days7CMO:0002771skin water level to skin dry weight ratioskin h2o ml/g1.223ml/g0.0320.0847MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (0.5 ml) (for 8 days)99139standard rat chow (for 8 days)sunitinib (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin sodium amountRS:0000916WKY/NHsdmale0 days8CMO:0002769skin sodium level to skin dry weight ratiommol/g0.164REQUEST NEW VALUE0.0090.0255MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99134controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin sodium amountRS:0000916WKY/NHsdmale0 days7CMO:0002769skin sodium level to skin dry weight ratiommol/g0.144REQUEST NEW VALUE0.0050.0132MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99133controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin sodium amountRS:0000916WKY/NHsdmale0 days8CMO:0002769skin sodium level to skin dry weight ratiommol/g0.112REQUEST NEW VALUE0.0020.0057MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99132standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin sodium amountRS:0000916WKY/NHsdmale0 days7CMO:0002769skin sodium level to skin dry weight ratiommol/g0.11REQUEST NEW VALUE0.0030.0079MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99131standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0002770skin chloride level to skin dry weight ratioskin cl mmol/g0.073mmol/g0.0070.0198MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99138controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0002770skin chloride level to skin dry weight ratioskin cl mmol/g0.068mmol/g0.0060.0159MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99137controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0002770skin chloride level to skin dry weight ratioskin cl mmol/g0.052mmol/g0.0030.0085MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99136standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0002770skin chloride level to skin dry weight ratioskin cl mmol/g0.051mmol/g0.0030.0079MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99135standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0002775skin chloride level to skin water level ratioskin cl/h2o50mmol/l4.412.4451MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99154controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0002775skin chloride level to skin water level ratioskin cl/h2o48mmol/l4.812.6996MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99153controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0002775skin chloride level to skin water level ratioskin cl/h2o43mmol/l1.54.2426MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99152standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0002775skin chloride level to skin water level ratioskin cl/h2o42mmol/l2.46.3498MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99151standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0002775skin chloride level to skin water level ratioskin na/h2o108mmol/l4.412.4451MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99150controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0002775skin chloride level to skin water level ratioskin na/h2o101mmol/l3.910.3184MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skincontrolled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99149controlled sodium content diet (8 %) (for 8 days)0.9% sodium chloride solution (0.9 %) (for 8 days)vehicle control condition (0.5 ml) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days8CMO:0002775skin chloride level to skin water level ratioskin na/h2o92mmol/l1.54.2426MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days)99148standard rat chow (for 8 days)sunitinib (7 mg/kg/d) (for 8 days)
2238Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.skin chloride amountRS:0000916WKY/NHsdmale0 days7CMO:0002775skin chloride level to skin water level ratioskin na/h2o90mmol/l0.82.1166MMO:0000584ex vivo analysis of atomic composition following dry ashing0.0ashed skinstandard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days)99147standard rat chow (for 8 days)vehicle control condition (0.5 ml) (for 8 days)